Psilocybin, which is from magic mushrooms, is being studied for treatment-resistant depression and major depressive disorder.
In May 2025, the Treasury Department, as chair of the Committee on Foreign Investment in the United States (CFIUS), announced a new “fast track process to facilitate greater investment in U.S.